News

On August 27, 2025, Novavax announced that the U.S. FDA approved the Nuvaxovid 2025-2026 COVID-19 vaccine formula for adults 65 and older, as well as individuals ages 12-64 with underlying conditions ...
The Food and Drug Administration on Wednesday restricted access to COVID-19 vaccines by ending their emergency authorization ...
The American Academy of Pediatrics called the decision to limit children's access to COVID-19 vaccines “deeply troubling.” ...
We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Novavax, Inc. is one of them. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company specializing in ...